The top differentially expressed gene in the allograft pathway, CXCL9, is of particular interest, as the expression of the chemokine CXCL9 boosts T-cell tumor infiltration and inhibits tumor growth, angiogenesis, and metastasis [60,61]. This evidence concerns the gene CXCL9 and neoplasm.